Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial

This publication has 31 references indexed in Scilit:

• Contemporary Incidence, Predictors, and Outcomes of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions
  JACC: Cardiovascular Interventions, 2014
• Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
  The Lancet, 2013
• Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock
  New England Journal of Medicine, 2012
• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
  European Heart Journal, 2012
• Early revascularization is beneficial across all ages and a wide spectrum of cardiogenic shock severity: A pooled analysis of trials
  Acute Cardiac Care, 2011
• Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission*
  Critical Care Medicine, 2010
• Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction
  Circulation, 2009
• Prognostic Significance of Cystatin C in Patients With ST-Elevation Myocardial Infarction
  Circulation Journal, 2009
• Effect of Tilarginine Acetate in Patients With Acute Myocardial Infarction and Cardiogenic Shock
  JAMA, 2007
• Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock
  New England Journal of Medicine, 1999